Launching a drug development company with novel technology from academia
Our corporate group has worked with hundreds of entrepreneurs at this stage to help them optimally and efficiently select and form the appropriate legal entity
Kori Kaufman
Associate Director, Contracts Specialist
Black Civil Rights Employee Education Subcommittee Chair
she/her
Faber’s clients benefit from Kori’s more than twenty years of experience in the pharmaceutical and biotechnology industries.
She assists clients with contractual management for all types of clinical studies and works closely with both the client and clinical sites to ensure efficient contract review and negotiation.
Specifically, Kori assists clients with drafting and negotiating service, consulting and related agreements for preclinical development and clinical studies. She also helps clients prepare and manage agreements for US based and multi-national clinical trials, including CRO, vendor agreements and site clinical trial agreements.
Kori is the chair of Faber’s Black Civil Rights Education sub-committee as part of Faber’s commitment to equality, diversity and inclusion.
Specifically, Kori assists clients with drafting and negotiating service, consulting and related agreements for preclinical development and clinical studies. She also helps clients prepare and manage agreements for US based and multi-national clinical trials, including CRO, vendor agreements and site clinical trial agreements.
Kori is the chair of Faber’s Black Civil Rights Education sub-committee as part of Faber’s commitment to equality, diversity and inclusion.
More about Kori
Contracts Manager
Albany Molecular Research, Inc. (AMRI) (now Curia Global, Inc.)
- Responsible for agreements involving outsourced drug discovery and commercial manufacture of API
- Worked with AMRI’s international subsidiaries on corporate governance and compliance
- While a member of AMRI’s business development group, focused on proposal drafting and review, marketing and submissions for governmental contracts
Kori was previously employed at a bankruptcy law firm and as a field and laboratory supervisor on archaeological research projects in upstate New York and Central Mexico.
Kori completed doctorate level course work in Anthropology at the University at Albany, State University of New York, where she was awarded a graduate assistantship in research and teaching within the department.
- Multiple clinical trials sponsored by Deciphera Pharmaceuticals, LLC including multinational Phase 1 and Phase 3 trials involving sites in North America, Europe, South America, Asia and Australia
- A Phase 1 clinical trial sponsored by CG Pharmaceuticals, Inc. involving sites in the United States
- Phase 1b and a Phase 2 clinical trials sponsored by Sorrento Therapeutics, Inc. involving sites in the United States
- A Phase 1 clinical trial sponsored by Schrödinger, Inc. involving sites in the United States
Kori is a member of the Drug Information Association and Model Agreement and Guidelines International.
Contracts Manager
Albany Molecular Research, Inc. (AMRI) (now Curia Global, Inc.)
- Responsible for agreements involving outsourced drug discovery and commercial manufacture of API
- Worked with AMRI’s international subsidiaries on corporate governance and compliance
- While a member of AMRI’s business development group, focused on proposal drafting and review, marketing and submissions for governmental contracts
Kori was previously employed at a bankruptcy law firm and as a field and laboratory supervisor on archaeological research projects in upstate New York and Central Mexico.
Kori completed doctorate level course work in Anthropology at the University at Albany, State University of New York, where she was awarded a graduate assistantship in research and teaching within the department.
- Multiple clinical trials sponsored by Deciphera Pharmaceuticals, LLC including multinational Phase 1 and Phase 3 trials involving sites in North America, Europe, South America, Asia and Australia
- A Phase 1 clinical trial sponsored by CG Pharmaceuticals, Inc. involving sites in the United States
- Phase 1b and a Phase 2 clinical trials sponsored by Sorrento Therapeutics, Inc. involving sites in the United States
- A Phase 1 clinical trial sponsored by Schrödinger, Inc. involving sites in the United States
Kori is a member of the Drug Information Association and Model Agreement and Guidelines International.
Related Content
Interested in working with Kori?
Our team is eager to learn more about your project